<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Sickle Cell Disease Advocates of Minnesota &#187; Hydroxyurea</title>
	<atom:link href="http://www.scdam.org/category/learn/hydroxyurea/feed" rel="self" type="application/rss+xml" />
	<link>http://www.scdam.org</link>
	<description>SCDAM: Sickle Cell Advocacy: Let&#039;s Do this</description>
	<lastBuildDate>Thu, 05 Aug 2010 09:39:02 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>What is Hydroxyurea (HU)</title>
		<link>http://www.scdam.org/hydroxyurea</link>
		<comments>http://www.scdam.org/hydroxyurea#comments</comments>
		<pubDate>Sat, 27 Dec 2008 06:51:43 +0000</pubDate>
		<dc:creator>Josephine Anuforo</dc:creator>
				<category><![CDATA[Hydroxyurea]]></category>
		<category><![CDATA[Sickle Cell Disease]]></category>

		<guid isPermaLink="false">http://www.scdam.org/announcing/what-is-hydroxyurea-hu/</guid>
		<description><![CDATA[Hydroxyurea (HU) is an anti-neoplastic agent that stimulates increased synthesis of fetal hemoglobin (Hb-F).  Hydroxyurea  is the generic drug name for this medication.  Droxia ™ and Hydrea™ are common brand names of hydroxyurea.  It was originally available in a pink and purple oval capsule form for adults but now it is available in a white [...]]]></description>
		<wfw:commentRss>http://www.scdam.org/hydroxyurea/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Letter to the Emergency Physician</title>
		<link>http://www.scdam.org/letter-to-the-emergency-physician</link>
		<comments>http://www.scdam.org/letter-to-the-emergency-physician#comments</comments>
		<pubDate>Sun, 11 Sep 2005 04:17:36 +0000</pubDate>
		<dc:creator>Executive Board</dc:creator>
				<category><![CDATA[Blood Transfusion]]></category>
		<category><![CDATA[Hydroxyurea]]></category>
		<category><![CDATA[Newborn Screening]]></category>
		<category><![CDATA[Sickle Cell Disease]]></category>

		<guid isPermaLink="false">http://www.scdam.org/?p=58</guid>
		<description><![CDATA[September 10, 2005 Dear Emergency Department Physician Director, Treatment of Minnesota patients with sickle cell disease has been refined in recent years, resulting in improved patient outcomes and fewer emergency room visits. However, because of the nature of sickle cell disease, affected patients will continue to present to emergency rooms for evaluation of new symptoms [...]]]></description>
		<wfw:commentRss>http://www.scdam.org/letter-to-the-emergency-physician/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
